Global Drugs For Short Bowel Syndrome Market Insights And Forecast To 2028

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 GLP-2
1.2.3 Growth Hormone
1.2.4 Glutamine
1.2.5 Other
1.3 Market by Application
1.3.1 Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Short Bowel Syndrome Market Perspective (2017-2028)
2.2 Drugs for Short Bowel Syndrome Growth Trends by Region
2.2.1 Drugs for Short Bowel Syndrome Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Drugs for Short Bowel Syndrome Historic Market Size by Region (2017-2022)
2.2.3 Drugs for Short Bowel Syndrome Forecasted Market Size by Region (2023-2028)
2.3 Drugs for Short Bowel Syndrome Market Dynamics
2.3.1 Drugs for Short Bowel Syndrome Industry Trends
2.3.2 Drugs for Short Bowel Syndrome Market Drivers
2.3.3 Drugs for Short Bowel Syndrome Market Challenges
2.3.4 Drugs for Short Bowel Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Short Bowel Syndrome Players by Revenue
3.1.1 Global Top Drugs for Short Bowel Syndrome Players by Revenue (2017-2022)
3.1.2 Global Drugs for Short Bowel Syndrome Revenue Market Share by Players (2017-2022)
3.2 Global Drugs for Short Bowel Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Short Bowel Syndrome Revenue
3.4 Global Drugs for Short Bowel Syndrome Market Concentration Ratio
3.4.1 Global Drugs for Short Bowel Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Short Bowel Syndrome Revenue in 2021
3.5 Drugs for Short Bowel Syndrome Key Players Head office and Area Served
3.6 Key Players Drugs for Short Bowel Syndrome Product Solution and Service
3.7 Date of Enter into Drugs for Short Bowel Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Short Bowel Syndrome Breakdown Data by Type
4.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Type (2017-2022)
4.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Type (2023-2028)
5 Drugs for Short Bowel Syndrome Breakdown Data by Application
5.1 Global Drugs for Short Bowel Syndrome Historic Market Size by Application (2017-2022)
5.2 Global Drugs for Short Bowel Syndrome Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Drugs for Short Bowel Syndrome Market Size (2017-2028)
6.2 North America Drugs for Short Bowel Syndrome Market Size by Type
6.2.1 North America Drugs for Short Bowel Syndrome Market Size by Type (2017-2022)
6.2.2 North America Drugs for Short Bowel Syndrome Market Size by Type (2023-2028)
6.2.3 North America Drugs for Short Bowel Syndrome Market Share by Type (2017-2028)
6.3 North America Drugs for Short Bowel Syndrome Market Size by Application
6.3.1 North America Drugs for Short Bowel Syndrome Market Size by Application (2017-2022)
6.3.2 North America Drugs for Short Bowel Syndrome Market Size by Application (2023-2028)
6.3.3 North America Drugs for Short Bowel Syndrome Market Share by Application (2017-2028)
6.4 North America Drugs for Short Bowel Syndrome Market Size by Country
6.4.1 North America Drugs for Short Bowel Syndrome Market Size by Country (2017-2022)
6.4.2 North America Drugs for Short Bowel Syndrome Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Drugs for Short Bowel Syndrome Market Size (2017-2028)
7.2 Europe Drugs for Short Bowel Syndrome Market Size by Type
7.2.1 Europe Drugs for Short Bowel Syndrome Market Size by Type (2017-2022)
7.2.2 Europe Drugs for Short Bowel Syndrome Market Size by Type (2023-2028)
7.2.3 Europe Drugs for Short Bowel Syndrome Market Share by Type (2017-2028)
7.3 Europe Drugs for Short Bowel Syndrome Market Size by Application
7.3.1 Europe Drugs for Short Bowel Syndrome Market Size by Application (2017-2022)
7.3.2 Europe Drugs for Short Bowel Syndrome Market Size by Application (2023-2028)
7.3.3 Europe Drugs for Short Bowel Syndrome Market Share by Application (2017-2028)
7.4 Europe Drugs for Short Bowel Syndrome Market Size by Country
7.4.1 Europe Drugs for Short Bowel Syndrome Market Size by Country (2017-2022)
7.4.2 Europe Drugs for Short Bowel Syndrome Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Short Bowel Syndrome Market Size (2017-2028)
8.2 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Type
8.2.1 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Drugs for Short Bowel Syndrome Market Share by Type (2017-2028)
8.3 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Application
8.3.1 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Drugs for Short Bowel Syndrome Market Share by Application (2017-2028)
8.4 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region
8.4.1 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Drugs for Short Bowel Syndrome Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Drugs for Short Bowel Syndrome Market Size (2017-2028)
9.2 Latin America Drugs for Short Bowel Syndrome Market Size by Type
9.2.1 Latin America Drugs for Short Bowel Syndrome Market Size by Type (2017-2022)
9.2.2 Latin America Drugs for Short Bowel Syndrome Market Size by Type (2023-2028)
9.2.3 Latin America Drugs for Short Bowel Syndrome Market Share by Type (2017-2028)
9.3 Latin America Drugs for Short Bowel Syndrome Market Size by Application
9.3.1 Latin America Drugs for Short Bowel Syndrome Market Size by Application (2017-2022)
9.3.2 Latin America Drugs for Short Bowel Syndrome Market Size by Application (2023-2028)
9.3.3 Latin America Drugs for Short Bowel Syndrome Market Share by Application (2017-2028)
9.4 Latin America Drugs for Short Bowel Syndrome Market Size by Country
9.4.1 Latin America Drugs for Short Bowel Syndrome Market Size by Country (2017-2022)
9.4.2 Latin America Drugs for Short Bowel Syndrome Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Short Bowel Syndrome Market Size (2017-2028)
10.2 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Type
10.2.1 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Drugs for Short Bowel Syndrome Market Share by Type (2017-2028)
10.3 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Application
10.3.1 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Drugs for Short Bowel Syndrome Market Share by Application (2017-2028)
10.4 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country
10.4.1 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Drugs for Short Bowel Syndrome Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Ardelyx
11.1.1 Ardelyx Company Details
11.1.2 Ardelyx Business Overview
11.1.3 Ardelyx Drugs for Short Bowel Syndrome Introduction
11.1.4 Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.1.5 Ardelyx Recent Developments
11.2 Emmaus Life Sciences
11.2.1 Emmaus Life Sciences Company Details
11.2.2 Emmaus Life Sciences Business Overview
11.2.3 Emmaus Life Sciences Drugs for Short Bowel Syndrome Introduction
11.2.4 Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.2.5 Emmaus Life Sciences Recent Developments
11.3 GLyPharma Therapeutic
11.3.1 GLyPharma Therapeutic Company Details
11.3.2 GLyPharma Therapeutic Business Overview
11.3.3 GLyPharma Therapeutic Drugs for Short Bowel Syndrome Introduction
11.3.4 GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.3.5 GLyPharma Therapeutic Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Drugs for Short Bowel Syndrome Introduction
11.4.4 Merck Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.4.5 Merck Recent Developments
11.5 Naia Pharmaceuticals
11.5.1 Naia Pharmaceuticals Company Details
11.5.2 Naia Pharmaceuticals Business Overview
11.5.3 Naia Pharmaceuticals Drugs for Short Bowel Syndrome Introduction
11.5.4 Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.5.5 Naia Pharmaceuticals Recent Developments
11.6 Nutrinia
11.6.1 Nutrinia Company Details
11.6.2 Nutrinia Business Overview
11.6.3 Nutrinia Drugs for Short Bowel Syndrome Introduction
11.6.4 Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.6.5 Nutrinia Recent Developments
11.7 OxThera
11.7.1 OxThera Company Details
11.7.2 OxThera Business Overview
11.7.3 OxThera Drugs for Short Bowel Syndrome Introduction
11.7.4 OxThera Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.7.5 OxThera Recent Developments
11.8 Sancilio & Company
11.8.1 Sancilio & Company Company Details
11.8.2 Sancilio & Company Business Overview
11.8.3 Sancilio & Company Drugs for Short Bowel Syndrome Introduction
11.8.4 Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.8.5 Sancilio & Company Recent Developments
11.9 Takeda
11.9.1 Takeda Company Details
11.9.2 Takeda Business Overview
11.9.3 Takeda Drugs for Short Bowel Syndrome Introduction
11.9.4 Takeda Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.9.5 Takeda Recent Developments
11.10 Zealand Pharma
11.10.1 Zealand Pharma Company Details
11.10.2 Zealand Pharma Business Overview
11.10.3 Zealand Pharma Drugs for Short Bowel Syndrome Introduction
11.10.4 Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2017-2022)
11.10.5 Zealand Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of GLP-2
Table 3. Key Players of Growth Hormone
Table 4. Key Players of Glutamine
Table 5. Key Players of Other
Table 6. Global Drugs for Short Bowel Syndrome Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Drugs for Short Bowel Syndrome Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Drugs for Short Bowel Syndrome Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Drugs for Short Bowel Syndrome Market Share by Region (2017-2022)
Table 10. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Drugs for Short Bowel Syndrome Market Share by Region (2023-2028)
Table 12. Drugs for Short Bowel Syndrome Market Trends
Table 13. Drugs for Short Bowel Syndrome Market Drivers
Table 14. Drugs for Short Bowel Syndrome Market Challenges
Table 15. Drugs for Short Bowel Syndrome Market Restraints
Table 16. Global Drugs for Short Bowel Syndrome Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Drugs for Short Bowel Syndrome Revenue Share by Players (2017-2022)
Table 18. Global Top Drugs for Short Bowel Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Short Bowel Syndrome as of 2021)
Table 19. Ranking of Global Top Drugs for Short Bowel Syndrome Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Drugs for Short Bowel Syndrome Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Drugs for Short Bowel Syndrome Product Solution and Service
Table 23. Date of Enter into Drugs for Short Bowel Syndrome Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Drugs for Short Bowel Syndrome Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2017-2022)
Table 27. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Drugs for Short Bowel Syndrome Revenue Market Share by Type (2023-2028)
Table 29. Global Drugs for Short Bowel Syndrome Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Drugs for Short Bowel Syndrome Revenue Share by Application (2017-2022)
Table 31. Global Drugs for Short Bowel Syndrome Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Drugs for Short Bowel Syndrome Revenue Share by Application (2023-2028)
Table 33. North America Drugs for Short Bowel Syndrome Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Drugs for Short Bowel Syndrome Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Drugs for Short Bowel Syndrome Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Drugs for Short Bowel Syndrome Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Drugs for Short Bowel Syndrome Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Drugs for Short Bowel Syndrome Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Drugs for Short Bowel Syndrome Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Drugs for Short Bowel Syndrome Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Drugs for Short Bowel Syndrome Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Drugs for Short Bowel Syndrome Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Drugs for Short Bowel Syndrome Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Drugs for Short Bowel Syndrome Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Drugs for Short Bowel Syndrome Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Drugs for Short Bowel Syndrome Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Drugs for Short Bowel Syndrome Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Drugs for Short Bowel Syndrome Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Drugs for Short Bowel Syndrome Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Drugs for Short Bowel Syndrome Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Drugs for Short Bowel Syndrome Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Drugs for Short Bowel Syndrome Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Drugs for Short Bowel Syndrome Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Drugs for Short Bowel Syndrome Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Drugs for Short Bowel Syndrome Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Drugs for Short Bowel Syndrome Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Drugs for Short Bowel Syndrome Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Drugs for Short Bowel Syndrome Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Drugs for Short Bowel Syndrome Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Drugs for Short Bowel Syndrome Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Drugs for Short Bowel Syndrome Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Drugs for Short Bowel Syndrome Market Size by Country (2023-2028) & (US$ Million)
Table 63. Ardelyx Company Details
Table 64. Ardelyx Business Overview
Table 65. Ardelyx Drugs for Short Bowel Syndrome Product
Table 66. Ardelyx Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 67. Ardelyx Recent Developments
Table 68. Emmaus Life Sciences Company Details
Table 69. Emmaus Life Sciences Business Overview
Table 70. Emmaus Life Sciences Drugs for Short Bowel Syndrome Product
Table 71. Emmaus Life Sciences Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 72. Emmaus Life Sciences Recent Developments
Table 73. GLyPharma Therapeutic Company Details
Table 74. GLyPharma Therapeutic Business Overview
Table 75. GLyPharma Therapeutic Drugs for Short Bowel Syndrome Product
Table 76. GLyPharma Therapeutic Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 77. GLyPharma Therapeutic Recent Developments
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Drugs for Short Bowel Syndrome Product
Table 81. Merck Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 82. Merck Recent Developments
Table 83. Naia Pharmaceuticals Company Details
Table 84. Naia Pharmaceuticals Business Overview
Table 85. Naia Pharmaceuticals Drugs for Short Bowel Syndrome Product
Table 86. Naia Pharmaceuticals Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 87. Naia Pharmaceuticals Recent Developments
Table 88. Nutrinia Company Details
Table 89. Nutrinia Business Overview
Table 90. Nutrinia Drugs for Short Bowel Syndrome Product
Table 91. Nutrinia Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 92. Nutrinia Recent Developments
Table 93. OxThera Company Details
Table 94. OxThera Business Overview
Table 95. OxThera Drugs for Short Bowel Syndrome Product
Table 96. OxThera Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 97. OxThera Recent Developments
Table 98. Sancilio & Company Company Details
Table 99. Sancilio & Company Business Overview
Table 100. Sancilio & Company Drugs for Short Bowel Syndrome Product
Table 101. Sancilio & Company Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 102. Sancilio & Company Recent Developments
Table 103. Takeda Company Details
Table 104. Takeda Business Overview
Table 105. Takeda Drugs for Short Bowel Syndrome Product
Table 106. Takeda Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 107. Takeda Recent Developments
Table 108. Zealand Pharma Company Details
Table 109. Zealand Pharma Business Overview
Table 110. Zealand Pharma Drugs for Short Bowel Syndrome Product
Table 111. Zealand Pharma Revenue in Drugs for Short Bowel Syndrome Business (2017-2022) & (US$ Million)
Table 112. Zealand Pharma Recent Developments
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Short Bowel Syndrome Market Share by Type: 2021 VS 2028
Figure 2. GLP-2 Features
Figure 3. Growth Hormone Features
Figure 4. Glutamine Features
Figure 5. Other Features
Figure 6. Global Drugs for Short Bowel Syndrome Market Share by Application: 2021 VS 2028
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Drugs for Short Bowel Syndrome Report Years Considered
Figure 11. Global Drugs for Short Bowel Syndrome Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Drugs for Short Bowel Syndrome Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Drugs for Short Bowel Syndrome Market Share by Region: 2021 VS 2028
Figure 14. Global Drugs for Short Bowel Syndrome Market Share by Players in 2021
Figure 15. Global Top Drugs for Short Bowel Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs for Short Bowel Syndrome as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Drugs for Short Bowel Syndrome Revenue in 2021
Figure 17. North America Drugs for Short Bowel Syndrome Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Drugs for Short Bowel Syndrome Market Size Market Share by Type (2017-2028)
Figure 19. North America Drugs for Short Bowel Syndrome Market Size Market Share by Application (2017-2028)
Figure 20. North America Drugs for Short Bowel Syndrome Market Size Share by Country (2017-2028)
Figure 21. United States Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Drugs for Short Bowel Syndrome Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Drugs for Short Bowel Syndrome Market Size Market Share by Type (2017-2028)
Figure 25. Europe Drugs for Short Bowel Syndrome Market Size Market Share by Application (2017-2028)
Figure 26. Europe Drugs for Short Bowel Syndrome Market Size Share by Country (2017-2028)
Figure 27. Germany Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Drugs for Short Bowel Syndrome Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Drugs for Short Bowel Syndrome Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Drugs for Short Bowel Syndrome Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Drugs for Short Bowel Syndrome Market Size Share by Region (2017-2028)
Figure 37. China Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Drugs for Short Bowel Syndrome Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Drugs for Short Bowel Syndrome Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Drugs for Short Bowel Syndrome Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Drugs for Short Bowel Syndrome Market Size Share by Country (2017-2028)
Figure 47. Mexico Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Drugs for Short Bowel Syndrome Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Drugs for Short Bowel Syndrome Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Drugs for Short Bowel Syndrome Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Drugs for Short Bowel Syndrome Market Size Share by Country (2017-2028)
Figure 53. Turkey Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Drugs for Short Bowel Syndrome Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Ardelyx Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 57. Emmaus Life Sciences Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 58. GLyPharma Therapeutic Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 59. Merck Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 60. Naia Pharmaceuticals Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 61. Nutrinia Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 62. OxThera Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 63. Sancilio & Company Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 64. Takeda Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 65. Zealand Pharma Revenue Growth Rate in Drugs for Short Bowel Syndrome Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.